Product Specifications
| Specification | Details |
| Manufacturer / Brand | Hikma Pharmaceuticals USA |
| Manufacturer # / SKU | 00641602225 |
| NDC Number | 00641-6022-25 |
| Active Ingredient | Famotidine 10 mg / mL |
| Application | Histamine H2-Antagonist |
| Dosage Form | Injection, Solution |
| Strength | 20 mg per 2 mL (10 mg/mL) |
| Container Type | Single-Dose Vial |
| Preservative Status | Preservative-Free |
| Storage Requirements | Requires Refrigeration (2 C to 8 C / 36 F to 46 F) |
| Packaging / Sold As | Box of 25 Vials |
| UNSPSC Code | 51171902 |
Key Features
-
Preservative-Free Formula: Ideal for patients with sensitivities to common pharmaceutical preservatives and suitable for single-use clinical applications.
-
Rapid Action: After intravenous administration, the maximum antisecretory effect is achieved within 30 minutes, providing fast relief for acute gastric issues.
-
Versatile Indications: Effectively treats duodenal ulcers, gastric ulcers, and GERD, and is used for the reduction of risk in upper GI bleeding for high-risk patients.
-
Standard Potency: Provides 10 mg per mL, allowing for easy calculation and administration of the standard 20 mg dose.
-
Hospital-Grade Supply: Packaged in a box of 25 single-dose vials to meet the inventory needs of pharmacy departments and surgical centers.
Usage & Administration
-
Administration: For intravenous use only. Can be administered as an injection over at least 2 minutes or as an infusion over 15 to 30 minutes.
-
Dosage (Adults): The recommended dosage is 20 mg every 12 hours.
-
Transition to Oral: Clinicians should discontinue injectable use and switch the patient to oral famotidine as soon as they can tolerate oral treatment.
-
Light Protection: Protect the solution from light during storage by keeping vials in the original carton.
⚠️ Caution: Requires refrigeration. Do not freeze. If the solution is discolored or contains particulate matter, it should not be used.
⚠️ Renal Impairment: Dosage adjustments may be necessary for patients with moderate or severe renal insufficiency to prevent accumulation of the drug.





